Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update.
Recordati S.p.A. has updated its ongoing share buyback program, purchasing 63,381 shares between October 28 and November 1, 2024, at an average price of €53.1691. This initiative supports the company’s stock option and incentive plans, enhancing value for shareholders. Recordati, a global pharmaceutical group, remains committed to addressing both common and rare health challenges.
For further insights into IT:REC stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Earnings Report Gives Canada Goose (TSE:GOOS) an Edge
- Phillip Securities Analyst Lifts Meta Price Target on Solid AI Potential
- Insider Trade: Carvana CFO Accumulates Shares Worth $37.7M
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
